HK inno.N and GC Cell signed a joint research and development contract for creating new cell therapies last Thursday.Under this contract, the two companies plan to develop immuno-anticancer cell therapies for solid cancer using the HLA-G target-based platform. HK inno.N will develop CAR-T cell thera
Lunit said it has signed a contract with FujiFilm Thailand and Microsoft to supply its artificial intelligence-based screening solutions to Bumrungrad International Hospital in Bangkok, Thailand.Under the accord, Lunit will supply Lunit INSIGHT CXR, a Conformite Europeenne (CE)-marked chest X-ray an
Experts discussed the effectiveness of emerging new migraine drugs at an online conference hosted by the Korean Headache Society (KHS) on Sunday.Twenty-five speakers gave lectures and presentations, and 280 members of the KHS participated in the event.Headache experts spoke mostly on new migraine me
The government has unified the names of all medical institutions that provide treatment for Covid-19 as "Respiratory Patient Treatment Center" as of Friday.Among the 12,601 Respiratory Patient Treatment Centers secured by quarantine officials, the government designated 6,206 "one-stop" Covid-19 trea
Zuellig Pharma Korea said on Friday that it appointed Dr. Marc Franck, former CEO of Zuellig Pharma Vietnam, as the new head of the Korean branch.Over the past 22 years, he has served in senior management positions in various countries where DKSH and Zuellig Pharma corporations are located, speciali
A research team from Korea University's Anam Hospital and Soongsil University discovered that high blood pressure is closely associated with infectious endocarditis through a recent domestic big data analysis.Infectious endocarditis is a fatal infectious disease with high mortality rates of about 20
Immunovant Sciences, the U.S. partner of Hanall Biopharma, is speeding up a phase 3 trial of HL161 (batoclimab), an autoimmune disease treatment candidate that it licensed from Hanall.Hanall Biopharma said Immunovant started the phase 3 study of HL161 (Immunovant’s pipeline name: IMVT-1401) to treat
Korean diagnostic agent developers and manufacturers have recently announced the completion of monkeypox test devices but healthcare experts said there would be little demand for testing.On Thursday, Wells Bio said it finished R&D of the monkeypox diagnostic agent, “careGENE MPXV detection kit.” Wel
Myongji Hospital has published a study, which calls for hospitals to manage respiratory symptoms intensively until four weeks after Covid-19 infection, and take a multidisciplinary treatment approach four weeks after the onset of complex symptoms.A hospital research team, led by Professor Jung Young
The ruling People Power Party (PPP) clinched a landslide victory in local elections on June 1. Although the new government started with the lowest approval ratings compared to any previous government, the local elections boosted its insufficient political power. The political season has ended. Now,
Pharmbio Korea said on Friday that the company has signed an exclusive supply license agreement for TYMLOS (ingredient name abaloparatide), an osteoporosis treatment of U.S. biopharmaceutical company Radius Health.Osteoporosis is a medical condition that occurs when bones become brittle and fragile
The following article has been provided by Vetter Pharma International GmbH as part of its public relations activities. Korea Biomedical Review has no relationship with and bears no responsibility for the contents and opinions in it. – Ed. The demand for complex, often life-saving drug substances su
Korea ranked first in the “Covid Resilience Ranking," an index evaluated by Bloomberg, a U.S. media company, on which country is the best to live in during the Covid-19 pandemic.Bloomberg has published the rankings of 53 countries every month since November 2020, when the world reported the first Co
Daewon Pharmaceutical's plan for the overseas advance of its non-steroidal anti-inflammatory drug (NSAID), Pelubi, has ground to a halt because of the prolonging Russian war in Ukraine.Daewon had conducted domestic clinical trials for Pelubi for the past two years to advance to Russia. The company r
T&R Biofab, a 3D bioprinting company, said Thursday that it has obtained a Japanese patent for heart disease treatment technology using induced pluripotent stem cells (iPSCs).The technology is used to manufacture a 3D micro cardiac spheroid, a three-dimensional heart structure of uniform 100 microme
Various experts in the Asia-Pacific region are now stressing the need to focus on routine care as the Covid-19 pandemic enters an endemic phase."A return to routine care is urgently needed to prevent non-Covid-19-related deaths," Professor Ivan Hung, chief of the Infectious Disease Division at the U
Long-term use of aspirin by hepatitis B patients can reduce liver cancer and liver disease-related deaths by 16 and 21 percent, Severance Hospital said Thursday, citing a recent study by its researchers.Hepatitis B causes an immune reaction due to hepatitis B virus (HBV) infection, leading to liver
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed an ultra-sensitive sensor platform that can detect human body temperature in real-time with the naked eye and without electronic devices' aid.The technology detects the temperature through color change by ap
Revlimid maintenance therapy to treat multiple myeloma (MM) passed the health insurance review agency’s reimbursement review four years after winning the license in Korea.The review committee also expanded the reimbursement criteria for immunotherapy Opdivo (nivolumab), which obtained broadened indi
Daewoong Pharmaceutical said Thursday that it has signed a contract development and manufacturing organization (CDMO) agreement with Yonsei University Wonju College of Medicine (YUWCM) to develop stem cell-based hearing loss therapies.With this contract, the two institutions will collaborate to esta